(Q40677014)

22 September 2017

title

Humanized anti-interleukin-6 receptor monoclonal antibody induced apoptosis of fresh and cloned human myeloma cells in vitro (English)

1 reference

22 September 2017

Toshiyuki Hirata

1

1 reference

22 September 2017

Chihiro Shimazaki

2

1 reference

22 September 2017

Toshiya Sumikuma

3

1 reference

22 September 2017

Eishi Ashihara

4

1 reference

22 September 2017

Hideo Goto

5

1 reference

22 September 2017

Tohru Inaba

6

1 reference

22 September 2017

Yasuo Koishihara

7

1 reference

22 September 2017

Masao Nakagawa

8

1 reference

22 September 2017

publication date

1 April 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

27

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

343-349

1 reference

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Up-regulation of interleukin (IL)-6 receptor gene expression in vitro and in vivo in IL-6 deprived myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Mechanism of apoptosis suppression by phorbol ester in IL-6-starved murine plasmacytomas: role of PKC modulation and cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Interleukin-6 inhibits apoptosis of malignant plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900179-0

7 January 2021

10.1016/S0145-2126(02)00179-0

Identifiers

DOI

1 reference

22 September 2017

1 reference